- Home
- ORGO vs ASLE Comparison
ORGO vs ASLE Comparison
Compare ORGO & ASLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORGO | ASLE |
|---|---|---|
| Founded | 1985 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 348.6M | 299.0M |
| IPO Year | 2016 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ORGO | ASLE |
|---|---|---|
| Price | $2.40 | $6.83 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $8.50 | $7.00 |
| AVG Volume (30 Days) | ★ 1.7M | 205.7K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1600.00 | 63.64 |
| EPS | 0.15 | ★ 0.18 |
| Revenue | ★ $564,169,000.00 | $335,286,000.00 |
| Revenue This Year | N/A | $23.41 |
| Revenue Next Year | $26.27 | $6.80 |
| P/E Ratio | ★ $15.90 | $38.00 |
| Revenue Growth | ★ 17.04 | N/A |
| 52 Week Low | $2.21 | $5.56 |
| 52 Week High | $7.08 | $9.08 |
Technical Indicators
Market Signals| Indicator | ORGO | ASLE |
|---|---|---|
| Relative Strength Index (RSI) | 44.54 | 54.05 |
| Support Level | $2.26 | $5.92 |
| Resistance Level | $2.60 | $7.16 |
| Average True Range (ATR) | 0.13 | 0.20 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 43.88 | 57.25 |
Price Performance
Historical ComparisonAbout ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About ASLE AerSale Corporation
AerSale Corp offers full-service support to owners and operators of mid-life commercial aircraft. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing various maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. AerSale also offers asset management services to owners of end-of-life aircraft and engine portfolios. The company has two reportable segments: Asset Management Solutions and TechOps. Maximum revenue is generated from the Asset Management Solutions segment, which comprises activities to extract value from strategic asset acquisitions through leasing, trading, or disassembling for product sales. Geographically, the company derives maximum revenue from its domestic market.